Toggle navigation
Home
Search
Services
Blog
Contact
About
Transdermal, Non-Invasive Monitoring of Medication Ingestion-281033009
Sequella, Inc., Rockville, MD, United States
Search grants from Sequella, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Optical monitoring of cerebral oxygenation in infants
Imaging COX-2 Gene Expression in Inflammation and Tumors
HIV/AIDS It Support to the Nlm
Immunobiology of Guinea Pig Inclusion Conjunctivitis
Mathematical Sciences: Applications of Topology to Problemsin Computation
Recently added grants:
The molecular basis for the role of apolipoprotein A-II in cholesterol and triglyceride metabolism
Enabling Mass Spectrometry Analysis of the Sulfoproteome
Does VECAD at Schlemm canal cell-junctions determine IOP and glaucoma risk?
Characterizing the Complexity of Advanced Cancer Pain in the Home Context by Leveraging Smart Health Technology
The role of regulator of G protein signaling Gbeta5-R7 in neuronal control of body weight
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Small Business Innovation Research – Phase II (N44)
Project #
N44AA033009-001
Application #
6828889
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Sequella, Inc.
Department
Type
DUNS #
125129606
City
Rockville
State
MD
Country
United States
Zip Code
20850
Related projects
NIH 2004
N44 AA
Transdermal. Non-Invasive Monitoring of Medication Ingestion-281033009
/ Sequella, Inc.
NIH 2003
N44 AA
Transdermal, Non-Invasive Monitoring of Medication Ingestion-281033009
/ Sequella, Inc.
Comments
Be the first to comment on this grant